MyAverix Finance
TO · Healthcare
Novo Nordisk CDR (CAD Hedged) (NOVO)
Drug Manufacturers - General
Novo Nordisk CDR (CAD Hedged) (NOVO) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NOVO
Novo Nordisk CDR (CAD Hedged) (NOVO) — FAQ
What is NOVO's P/E ratio?
The price-to-earnings (P/E) ratio for Novo Nordisk CDR (CAD Hedged) (NOVO) is 18.00 (data as of 2026-03-22).
Does Novo Nordisk CDR (CAD Hedged) pay a dividend?
Dividend yield is not available in the current snapshot for Novo Nordisk CDR (CAD Hedged) (NOVO). Check the MyAverix Finance app for the latest dividend data.
What sector is Novo Nordisk CDR (CAD Hedged) in?
Novo Nordisk CDR (CAD Hedged) (NOVO) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is NOVO listed on?
NOVO is listed on TO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.